|
Volumn 137, Issue 4, 2018, Pages 405-407
|
Cardiovascular Outcomes and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME
|
Author keywords
diabetes mellitus peripheral arterial disease; sodium glucose cotransporter 2
|
Indexed keywords
EMPAGLIFLOZIN;
HEMOGLOBIN A1C;
PLACEBO;
BENZHYDRYL DERIVATIVE;
GLUCOSIDE;
ANGIOPLASTY;
ANKLE BRACHIAL INDEX;
ARTERY OCCLUSION;
ARTICLE;
BYPASS SURGERY;
CARDIOVASCULAR RISK;
CAUSE OF DEATH;
CEREBROVASCULAR ACCIDENT;
DRUG EFFECT;
DRUG SAFETY;
ESTIMATED GLOMERULAR FILTRATION RATE;
FOOT AMPUTATION;
HEALTH CARE QUALITY;
HEART FAILURE;
HEART INFARCTION;
HOSPITALIZATION;
HUMAN;
KIDNEY DISEASE;
MACROALBUMINURIA;
MORTALITY RATE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PERIPHERAL OCCLUSIVE ARTERY DISEASE;
PRIORITY JOURNAL;
RENAL REPLACEMENT THERAPY;
TREATMENT OUTCOME;
AGED;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
MALE;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
RISK FACTOR;
TIME FACTOR;
AGED;
BENZHYDRYL COMPOUNDS;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GLUCOSIDES;
HUMANS;
MALE;
MIDDLE AGED;
PERIPHERAL ARTERIAL DISEASE;
RISK ASSESSMENT;
RISK FACTORS;
SODIUM-GLUCOSE TRANSPORTER 2 INHIBITORS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 85034212680
PISSN: 00097322
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.117.032031 Document Type: Article |
Times cited : (143)
|
References (4)
|